Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.28 $0 (0%) YEWB stock closing price Oct 21, 2016 (Closing)

Financial analysis of Yew Bio Pharm involves more than just checking the Yew Bio Pharm stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the YEWB income statement also itemizes revenue, operating expenses, and profits for a quarter or year and reflects a QoQ revenue growth of $7.44M when compared to the same period in the past. The Yew Bio Pharm profit and loss statement for 2016-Q2 shows a profit of $1.31M. Profits have grown from $1.05M QoQ. Apart from this an investor should also check Yew Bio Pharm assets and Yew Bio Pharm free cash flow. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Get Income statement for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Yew Bio Pharm Net Sales or Revenues
Cost Of Goods Sold (COGS)14.41M7.22M15.52M3.57M2.28M1.17M0.9M0.29M0.42M0.52M
Yew Bio Pharm Gross Profit
Research & Development Expense----------
Selling General & Admin Expense0.34M0.31M0.46M0.48M0.48M0.47M0.41M0.51M0.22M0.16M
Income Before Depreciation Depletion Amortization1.3M1.07M1.32M0.93M1.89M0.99M0.61M0.89M1.41M1.37M
Depreciation Depletion Amortization----------
Non Operating Income--0.02M0.05M-0.11M-----
Interest Expense----------
Yew Bio Pharm Pretax Income
Provision for Income Taxes---0.04M--0.04M----
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.31M1.05M1.39M0.93M2.01M0.96M0.61M0.89M1.41M1.37M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS51.88M51.88M51.88M52.19M57.62M58.23M----
Average Shares used to compute Basic EPS51.88M51.88M51.88M52.16M52.13M52.13M----
Income Before Nonrecurring Items1.31M1.05M1.39M0.93M2.01M0.96M----
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
Yew Bio Pharm Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Yew Bio Pharm stock analysis. It helps to look at the following income statement items:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Yew Bio Pharm revenue chart) implies that the company is growing, which has been the case with Yew Bio Pharm. One must stay away from stocks whose revenues are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Yew Bio Pharm historical stock prices provides a lot of details about the firm. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield

Other Income Statements - Yew Bio-Pharm Group, Inc. Industry Peers

China Modern income statement, Ricebran income statement